These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 10317245

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Quality drugs and the Saskatchewan formulary.
    Johnson GE.
    Can J Hosp Pharm; 1975; 28(3):84-6. PubMed ID: 10316621
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The effect of generic competition on the price of brand-name drugs.
    Lexchin J.
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [Abstract] [Full Text] [Related]

  • 48. Biopharmaceutic equivalency and the role of the Food & Drug Administration.
    Hodges RM.
    Am J Hosp Pharm; 1968 Mar; 25(3):121-7. PubMed ID: 5658859
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. In U.S., biosimilars still await FDA decision.
    Finkelstein JB.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):435. PubMed ID: 16595775
    [No Abstract] [Full Text] [Related]

  • 52. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P, Chan CC, Carrano J, Gosnell M, Gu ZQ, Maule A, Sigvardson K, Zhang YF.
    Pharm Res; 2006 Feb 05; 23(2):440-6. PubMed ID: 16477396
    [No Abstract] [Full Text] [Related]

  • 53. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B.
    Food Drug Law J; 2008 Feb 05; 63(2):459-91. PubMed ID: 18561473
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Drug product quality.
    Exp Med Surg; 1971 Feb 05; 29(1):135-44. PubMed ID: 5147595
    [No Abstract] [Full Text] [Related]

  • 58. FDA-USP drug product problem reporting program--an update.
    Wheatley LS.
    Hosp Formul; 1979 Mar 05; 14(3):359-60, 365. PubMed ID: 10316797
    [No Abstract] [Full Text] [Related]

  • 59. FDA drug list: key to generic substitution.
    FDA Consum; 1979 Feb 05; 13(1):15-7. PubMed ID: 10308816
    [Abstract] [Full Text] [Related]

  • 60. Bioequivalence and narrow therapeutic index drugs.
    Benet LZ, Goyan JE.
    Pharmacotherapy; 1995 Feb 05; 15(4):433-40. PubMed ID: 7479195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.